Table 2.
HLA class I restricted epitopes (II)
| Number | Response AHB | Response CHB | K D | Reference |
|---|---|---|---|---|
| HBsEC-1 | 14/23 | N/A | N/A | [13] |
| HBsEC-2 | 6/13 | 1/15 | N/A | [9, 14] |
| HBsEC-3 | N/A | 16/17 | N/A | [8] |
| HBsEC-4 | 42/56 | 5/33 | N/A | [6, 8, 9, 14, 15] |
| HBsEC-5 | 2/4 | 0/12 | N/A | [14] |
| HBsCP-6 | <50 nM | |||
| HBsCP-7 | <50 nM | |||
| HBsCP-8 | <50 nM | |||
| HBsCP-9 | <50 nM | |||
| HBsCP-10 | >500 nM | |||
| HBcEC-11 | 41/59 | 9/30 | 50–10,000 nM | [6, 8, 9, 14–17] |
| HBcEC-12 | N/A | 1/1 | N/A | [18] |
| HBcEC-13 | N/A | 2/5 | >50 nM | [8] |
| HBcEC-14 | 7/12 | 0/11 | >500 nM | [19] |
| HBcEC-15 | N/A | 15/18 | >50 nM | [8] |
| HBcCP-16 | <50 nM | |||
| HBcCP-17 | >500 nM | |||
| HBcCP-18 | <50 nM | |||
| HBcCP-19 | <50 nM | |||
| HBcCP-20 | 50–500 nM |
All K D values are in silico predictions by NetMHC version 3.2 8mer predictions. HBsEC: HBsAg experimentally confirmed; HBsCP: HBsAg computer predicted; HBcEC: HBcAg experimentally confirmed; HBcCP: HBcAg computer predicted. N/A: Not available, AHB and CHB referres to number of responders in previous studies of acute hepatitis B (AHB) and chronic hepatitis B patients (CHB)